Pediatric multiple sclerosis: Current concepts and consensus definitions

Autoimmune Diseases

Volumn 2013, Issue , 2013, Pages

  Pena, Joaquin A ^a   Lotze, Timothy E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA1A INTERFERON; CALCITRIOL; CIGARETTE SMOKE; CONTACTIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DACLIZUMAB; EPSTEIN BARR VIRUS ANTIGEN 1; FINGOLIMOD; FUMARIC ACID DIMETHYL ESTER; GADOLINIUM; GLATIRAMER; HEPATITIS B VACCINE; HLA DRB1 ANTIGEN; IMMUNOGLOBULIN; INTERFERON; INTERFERON BETA SERINE; METHYLPREDNISOLONE; MITOXANTRONE; MONOCLONAL ANTIBODY; MYELIN; NATALIZUMAB; OLIGOCLONAL BAND; TERIFLUNOMIDE; VIRUS ANTIGEN; VITAMIN D;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; AFRICAN AMERICAN; AGE DISTRIBUTION; B LYMPHOCYTE; BRAIN ATROPHY; BRAIN EDEMA; CANADA; CAUCASIAN; CEREBROSPINAL FLUID ANALYSIS; CHILDHOOD DISEASE; COGNITIVE DEFECT; CONTRAST ENHANCEMENT; CYTOMEGALOVIRUS INFECTION; DEMYELINATING DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG APPROVAL; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG WITHDRAWAL; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS INFECTION; ETHNIC DIFFERENCE; EVOKED VISUAL RESPONSE; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES ZOSTER; HIGH RISK POPULATION; HISPANIC; HUMAN; HUMAN PARVOVIRUS B19; IMMIGRANT; IMMUNIZATION; INCIDENCE; INNATE IMMUNITY; LATERAL BRAIN VENTRICLE; MEDICATION COMPLIANCE; MIGRATION; MONONUCLEOSIS; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; NEGRO; NETHERLANDS; NEUROIMAGING; NONMYELINATED NERVE; NORTH AMERICA; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; OPTIC NEURITIS; OPTICAL COHERENCE TOMOGRAPHY; PARVOVIRUS INFECTION; PATHOGENESIS; PEDIATRIC MULTIPLE SCLEROSIS; PLASMAPHERESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; RACE DIFFERENCE; RECURRENT DISEASE; RELAPSE; RESIDENTIAL AREA; RETINAL NERVE FIBER LAYER THICKNESS; REVIEW; SENSITIVITY AND SPECIFICITY; SEX RATIO; SMOKING; SUNLIGHT; T LYMPHOCYTE; TREATMENT DURATION; ULTRAVIOLET RADIATION; UNITED STATES; VIRUS INFECTION; VISUAL IMPAIRMENT; VITAMIN D DEFICIENCY;

EID: 84888861309     PISSN: None     EISSN: 20900430     Source Type: Journal    
DOI: 10.1155/2013/673947     Document Type: Review

References (91)

1. Duquette P., Murray T. J., Pleines J., Ebers G. C., Sadovnick D., Weldon P., Warren S., Paty D. W., Upton A., Hader W., Nelson R., Auty A., Neufeld B., Meltzer C., Multiple sclerosis in childhood: clinical profile in 125 patients. Journal of Pediatrics 1987 111 3 359 363 2-s2.0-0023640304 (Pubitemid 17157505)
2. Ghezzi A., Deplano V., Faroni J., Grasso M. G., Liguori M., Marrosu G., Pozzilli C., Simone I. L., Zaffaroni M., Multiple sclerosis in childhood: clinical features of 149 cases. Multiple Sclerosis 1997 3 1 43 46 2-s2.0-0030924858 (Pubitemid 27234861)
3. Ruggieri M., Iannetti P., Polizzi A., Pavone L., Grimaldi L. M., Multiple sclerosis in children under 10 years of age. Neurological Sciences 2004 25 4 S326 S335 2-s2.0-10044223656 10.1007/s10072-004-0335-z (Pubitemid 39600426)
4. Krupp L. B., Banwell B., Tenembaum S., International Pediatric MS Study Group, Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 2007 68 16, supplement 2 S7 S12 10.1212/01.wnl.0000259422.44235.a8 (Pubitemid 46626001)
5. Krupp L. B., Tardieu M., Amato M. P., Banwell B., Chitnis T., Dale R. C., Ghezzi A., Hintzen R., Kornberg A., Pohl D., Rostasy K., Tenembaum S., Wassmer E., International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Multiple Sclerosis Journal 2013 19 10 1261 1267 10.1177/1352458513484547
6. Deryck O., Ketelaer P., Dubois B., Clinical characteristics and long term prognosis in early onset multiple sclerosis. Journal of Neurology 2006 253 6 720 723 2-s2.0-33745535607 10.1007/s00415-006-0095-1 (Pubitemid 43980141)
7. Renoux C., Vukusic S., Mikaeloff Y., Edan G., Clanet M., Dubois B., Debouverie M., Brochet B., Lebrun-Frenay C., Pelletier J., Moreau T., Lubetzki C., Vermersch P., Roullet E., Magy L., Tardieu M., Suissa S., Confavreux C., Natural history of multiple sclerosis with childhood onset. New England Journal of Medicine 2007 356 25 2603 2613 2-s2.0-34250749606 10.1056/NEJMoa067597 (Pubitemid 46961005)
8. Langer-Gould A., Zhang J. L., Chung J., Yeung Y., Waubant E., Yao J., Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children. Neurology 2011 77 12 1143 1148 2-s2.0-80555156723 10.1212/WNL. 0b013e31822facdd
9. Banwell B., Kennedy J., Sadovnick D., Arnold D. L., Magalhaes S., Wambera K., Connolly M. B., Yager J., Mah J. K., Shah N., Sebire G., Meaney B., Dilenge M. E., Lortie A., Whiting S., Doja A., Levin S., Macdonald E. A., Meek D., Wood E., Lowry N., Buckley D., Yim C., Awuku M., Guimond C., Cooper P., Grand'maison F., Baird J. B., Bhan V., Bar-Or A., Incidence of acquired demyelination of the CNS in Canadian children. Neurology 2009 72 3 232 239 2-s2.0-59649087483 10.1212/01.wnl.0000339482.84392.bd
10. Ketelslegers I. A., Catsman-Berrevoets C. E., Neuteboom R. F., Boon M., van Dijk K. G. J., Eikelenboom M. J., Gooskens R. H. J. M., Niks E. H., Overweg-Plandsoen W. C. G., Peeters E. A. J., Peeters-Scholte C. M. P. C. D., Poll-The B. T., de Rijk-van Andel J. F., Samijn J. P. A., Snoeck I. N., Stroink H., Vermeulen R. J., Verrips A., Vles J. S. H., Willemsen M. A. A. P., Rodrigues Pereira R., Hintzen R. Q., Incidence of acquired demyelinating syndromes of the CNS in Dutch children: a nationwide study. Journal of Neurology 2012 259 9 1929 1935 2-s2.0-84857001465 10.1007/s00415-012-6441-6
11. Kennedy J., O'Connor P., Sadovnick A. D., Perara M., Yee I., Banwell B., Age at onset of multiple sclerosis may be influenced by place of residence during childhood rather than ancestry. Neuroepidemiology 2006 26 3 162 167 2-s2.0-33645655577 10.1159/000091658
12. Banwell B., Ghezzi A., Bar-Or A., Mikaeloff Y., Tardieu M., Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurology 2007 6 10 887 902 2-s2.0-34548619970 10.1016/S1474-4422(07)70242-9 (Pubitemid 47405001)
13. Chitnis T., Glanz B., Jaffin S., Healy B., Demographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United States. Multiple Sclerosis 2009 15 5 627 631 2-s2.0-65349094587 10.1177/1352458508101933
14. Yeh E. A., Chitnis T., Krupp L., Ness J., Chabas D., Kuntz N., Waubant E., Pediatric multiple sclerosis. Nature Reviews Neurology 2009 5 11 621 631 2-s2.0-70449528660 10.1038/nrneurol.2009.158
15. Chitnis T., Krupp L., Yeh A., Rubin J., Kuntz N., Strober J. B., Chabas D., Weinstock-Guttmann B., Ness J., Rodriguez M., Waubant E., Pediatric Multiple Sclerosis. Neurologic Clinics 2011 29 2 481 505 2-s2.0-79952854048 10.1016/j.ncl.2011.01.004
16. Mehta B. K., New hypotheses on sunlight and the geographic variability of multiple sclerosis prevalence. Journal of the Neurological Sciences 2010 292 1-2 5 10 2-s2.0-77949873982 10.1016/j.jns.2010.02.004
17. Mowry E. M., Vitamin D: evidence for its role as a prognostic factor in multiple sclerosis. Journal of the Neurological Sciences 2011 311 1-2 19 22 2-s2.0-81255161781 10.1016/j.jns.2011.06.035
18. Chen S., Sims G. P., Xiao X. C., Yue Y. G., Chen S., Lipsky P. E., Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. Journal of Immunology 2007 179 3 1634 1647 2-s2.0-34548637038
19. Simpson S. Jr., Taylor B., Blizzard L., Ponsonby A. L., Pittas F., Tremlett H., Dwyer T., Gies P., van der Mei I., Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Annals of Neurology 2010 68 2 193 203 2-s2.0-77955291052 10.1002/ana.22043
20. Mowry E. M., Krupp L. B., Milazzo M., Chabas D., Strober J. B., Belman A. L., McDonald J. C., Oksenberg J. R., Bacchetti P., Waubant E., Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Annals of Neurology 2010 67 5 618 624 2-s2.0-77951713604 10.1002/ana.21972
21. Mowry E. M., Waubant E., McCulloch C. E., Okuda D. T., Evangelista A. A., Lincoln R. R., Gourraud P. A., Brenneman D., Owen M. C., Qualley P., Bucci M., Hauser S. L., Pelletier D., Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis. Annals of Neurology Journal 2012 72 2 234 240 10.1002/ana.23591
22. Ascherio A., Munger K. L., Lennette E. T., Spiegelman D., Hernán M. A., Olek M. J., Hankinson S. E., Hunter D. J., Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. Journal of the American Medical Association 2001 286 24 3083 3088 2-s2.0-0035956494 (Pubitemid 34016522)
23. Alotaibi S., Kennedy J., Tellier R., Stephens D., Banwell B., Epstein-Barr virus in pediatric multiple sclerosis. Journal of the American Medical Association 2004 291 15 1875 1879 2-s2.0-1942478620 10.1001/jama.291.15. 1875 (Pubitemid 38509501)
24. Banwell B., Krupp L., Kennedy J., Tellier R., Tenembaum S., Ness J., Belman A., Boiko A., Bykova O., Waubant E., Mah J. K., Stoian C., Kremenchutzky M., Bardini M. R., Ruggieri M., Rensel M., Hahn J., Weinstock-Guttman B., Yeh E. A., Farrell K., Freedman M., Iivanainen M., Sevon M., Bhan V., Dilenge M. E., Stephens D., Bar-Or A., Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurology 2007 6 9 773 781 2-s2.0-34547754534 10.1016/S1474-4422(07)70196-5 (Pubitemid 47238663)
25. Pohl D., Krone B., Rostasy K., Kahler E., Brunner E., Lehnert M., Wagner H. J., Gärtner J., Hanefeld F., High seroprevalence of Epstein-Barr virus in children with multiple sclerosis. Neurology 2006 67 11 2063 2065 2-s2.0-33845706602 10.1212/01.wnl.0000247665.94088.8d (Pubitemid 44967394)
26. Waubant E., Mowry E. M., Krupp L., Chitnis T., Yeh E. A., Kuntz N., Ness J., Chabas D., Strober J., McDonald J., Belman A., Milazzo M., Gorman M., Weinstock-Guttman B., Rodriguez M., Oksenberg J. R., James J. A., Common viruses associated with lower pediatric multiple sclerosis risk. Neurology 2011 76 23 1989 1995 2-s2.0-79958758673 10.1212/WNL.0b013e31821e552a
27. Pohl D., Epstein-Barr virus and multiple sclerosis. Journal of the Neurological Sciences 2009 286 1-2 62 64 2-s2.0-70349773294 10.1016/j.jns.2009. 03.028
28. Mikaeloff Y., Caridade G., Rossier M., Suissa S., Tardieu M., Hepatitis B vaccination and the risk of childhood-onset multiple sclerosis. Archives of Pediatrics and Adolescent Medicine 2007 161 12 1176 1182 2-s2.0-36849023932 10.1001/archpedi.161.12.1176 (Pubitemid 350223573)
29. Mikaeloff Y., Caridade G., Assi S., Tardieu M., Suissa S., Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination. Brain 2007 130 part 4 1105 1110 2-s2.0-34249701674 10.1093/brain/awl368 (Pubitemid 47355586)
30. Mikaeloff Y., Caridade G., Suissa S., Tardieu M., Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. Neurology 2009 72 10 873 880 2-s2.0-64049091131 10.1212/01.wnl.0000335762.42177.07
31. Mikaeloff Y., Caridade G., Tardieu M., Suissa S., Parental smoking at home and the risk of childhood-onset multiple sclerosis in children. Brain 2007 130 part 10 2589 2595 2-s2.0-34848909001 10.1093/brain/awm198 (Pubitemid 47511711)
32. Dyment D. A., Ebers G. C., Sadovnick A. D., Genetics of multiple sclerosis. Lancet Neurology 2004 3 2 104 110 2-s2.0-1642513783 10.1016/S1474-4422(03)00663-X (Pubitemid 38121313)
33. de Jager P. L., Jia X., Wang J., de Bakker P. I. W., Ottoboni L., Aggarwal N. T., Piccio L., Raychaudhuri S., Tran D., Aubin C., Briskin R., Romano S., Baranzini S. E., McCauley J. L., Pericak-Vance M. A., Haines J. L., Gibson R. A., Naeglin Y., Uitdehaag B., Matthews P. M., Kappos L., Polman C., McArdle W. L., Strachan D. P., Evans D., Cross A. H., Daly M. J., Compston A., Sawcer S. J., Weiner H. L., Hauser S. L., Hafler D. A., Oksenberg J. R., Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nature Genetics 2009 41 7 776 782 2-s2.0-67649876123 10.1038/ng.401
34. Derfuss T., Linington C., Hohlfeld R., Meinl E., Axo-glial antigens as targets in multiple sclerosis: implications for axonal and grey matter injury. Journal of Molecular Medicine 2010 88 8 753 761 2-s2.0-77956486042 10.1007/s00109-010-0632-3
35. Stys P. K., Zamponi G. W., van Minnen J., Geurts J. J., Will the real multiple sclerosis please stand up? Nature Reviews Neuroscience 2012 13 7 507 514 10.1038/nrn3275
36. Rostasy K., Withut E., Pohl D., Lange P., Ciesielcyk B., Diem R., Gärtner J., Otto M., Tau, phospho-tau, and S-100B in the cerebrospinal fluid of children with multiple sclerosis. Journal of Child Neurology 2005 20 10 822 825 2-s2.0-24744465369 10.1177/08830738050200100801 (Pubitemid 43124472)
37. Derfuss T., Parikh K., Velhin S., Braun M., Mathey E., Krumbholz M., Kumpfel T., Moldenhauer A., Rader C., Sonderegger P., Pollmann W., Tiefenthaller C., Bauers J., Lassmann H., Wekerle H., Karagogeos D., Hohlfeld R., Linington C., Meinl E., Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals. Proceedings of the National Academy of Sciences of the United States of America 2009 106 20 8302 8307 2-s2.0-66249105681 10.1073/pnas.0901496106
38. Mathey E. K., Derfuss T., Storch M. K., Williams K. R., Hales K., Woolley D. R., Al-Hayani A., Davies S. N., Rasband M. N., Olsson T., Moldenhauer A., Velhin S., Hohlfeld R., Meinl E., Linington C., Neurofascin as a novel target for autoantibody-mediated axonal injury. Journal of Experimental Medicine 2007 204 10 2363 2372 2-s2.0-34948864286 10.1084/jem.20071053 (Pubitemid 47529322)
39. Meinl E., Derfuss T., Krumbholz M., Pröbstel A. K., Hohlfeld R., Humoral autoimmunity in multiple sclerosis. Journal of the Neurological Sciences 2011 306 1-2 180 182 2-s2.0-79958771005 10.1016/j.jns.2010.08.009
40. Dhaunchak A. S., Becker C., Schulman H., de Faria O. Jr., Rajasekharan S., Banwell B., Colman D. R., Bar-Or A., Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis. Annals of Neurology 2012 71 5 601 613 2-s2.0-84860219699 10.1002/ana.22693
41. Van Noort J. M., Bsibsi M., Gerritsen W. H., van der Valk P., Bajramovic J. J., Steinman L., Amor S., α B-crystallin is a target for adaptive immune responses and a trigger of innate responses in preactive multiple sclerosis lesions. Journal of Neuropathology and Experimental Neurology 2010 69 7 694 703 2-s2.0-77954699176 10.1097/NEN.0b013e3181e4939c
42. Bennett J. L., Owens G. P., Cerebrospinal fluid proteomics: a new window for understanding human demyelinating disorders? Annals of Neurology 2012 71 5 587 588 2-s2.0-84860156051 10.1002/ana.23595
43. Polman C. H., Reingold S. C., Banwell B., Clanet M., Cohen J. A., Filippi M., Fujihara K., Havrdova E., Hutchinson M., Kappos L., Lublin F. D., Montalban X., O'Connor P., Sandberg-Wollheim M., Thompson A. J., Waubant E., Weinshenker B., Wolinsky J. S., Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Annals of Neurology 2011 69 2 292 302 2-s2.0-79952501096 10.1002/ana.22366
44. Neuteboom R. F., Boon M., Catsman Berrevoets C. E., Vles J. S., Gooskens R. H., Stroink H., Vermeulen R. J., Rotteveel J. J., Ketelslegers I. A., Peeters E., Poll-The B. T., de Rijk-van Andel J. F., Verrips A., Hintzen R. Q., Prognostic factors after a first attack of inflammatory CNS demyelination in children. Neurology 2008 71 13 967 973 2-s2.0-54049085469 10.1212/01.wnl. 0000316193.89691.e1
45. Wilejto M., Shroff M., Buncic J. R., Kennedy J., Goia C., Banwell B., The clinical features, MRI findings, and outcome of optic neuritis in children. Neurology 2006 67 2 258 262 2-s2.0-33747060190 10.1212/01.wnl.0000224757.69746. fb (Pubitemid 44305409)
46. Verhey L. H., Branson H. M., Shroff M. M., Callen D. J., Sled J. G., Narayanan S., Sadovnick A. D., Bar-Or A., Arnold D. L., Marrie R. A., Banwell B., MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study. The Lancet Neurology 2011 10 12 1065 1073 2-s2.0-81255170303 10.1016/S1474-4422(11)70250-2
47. Bigi S., Banwell B., Pediatric multiple sclerosis. Journal of Child Neurology 2012 27 11 1378 1383 10.1177/0883073812452784
48. Alper G., Wang L., Demyelinating optic neuritis in children. Journal of Child Neurology 2009 24 1 45 48 2-s2.0-59349085315 10.1177/0883073808321052
49. Miyazawa R., Ikeuchi Y., Tomomasa T., Ushiku H., Ogawa T., Morikawa A., Determinants of prognosis of acute transverse myelitis in children. Pediatrics International 2003 45 5 512 516 2-s2.0-0242408415 10.1046/j.1442-200X.2003. 01773.x (Pubitemid 37430749)
50. Borchers A. T., Gershwin M. E., Transverse myelitis. Autoimmunity Reviews 2012 11 3 231 248 2-s2.0-84855940328 10.1016/j.autrev.2011.05.018
51. Pidcock F. S., Krishnan C., Crawford T. O., Salorio C. F., Trovato M., Kerr D. A., Acute transverse myelitis in childhood: center-based analysis of 47 cases. Neurology 2007 68 18 1474 1480 2-s2.0-34247587235 10.1212/01.wnl. 0000260609.11357.6f (Pubitemid 46685917)
52. Pohl D., Tenembaum S., Treatment of acute disseminated encephalomyelitis. Current Treatment Options in Neurology 2012 14 3 264 275 2-s2.0-84859054142 10.1007/s11940-012-0170-0
53. Mar S., Lenox J., Benzinger T., Brown S., Noetzel M., Long-term prognosis of pediatric patients with relapsing acute disseminated encephalomyelitis. Journal of Child Neurology 2010 25 6 681 688 2-s2.0-77952917710 10.1177/0883073809343320
54. Lotze T. E., Northrop J. L., Hutton G. J., Ross B., Schiffman J. S., Hunter J. V., Spectrum of pediatric neuromyelitis optica. Pediatrics 2008 122 5 e1039 e1047 2-s2.0-58149144305 10.1542/peds.2007-2758
55. Mikaeloff Y., Suissa S., Vallée L., Lubetzki C., Ponsot G., Confavreux C., Tardieu M., First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability. Journal of Pediatrics 2004 144 2 246 252 2-s2.0-1542317607 10.1016/j.jpeds.2003.10.056 (Pubitemid 38869403)
56. Callen D. J. A., Shroff M. M., Branson H. M., Li D. K., Lotze T., Stephens D., Banwell B. L., Role of MRI in the differentiation of ADEM from MS in children. Neurology 2009 72 11 968 973 2-s2.0-64049117176 10.1212/01.wnl.0000338630.20412.45
57. Wingerchuk D. M., Neuromyelitis optica spectrum disorders. CONTINUUM Lifelong Learning in Neurology 2010 16 5 105 121 2-s2.0-78650722767 10.1212/01.CON.0000389937.69413.15
58. McKeon A., Lennon V. A., Lotze T., Tenenbaum S., Ness J. M., Rensel M., Kuntz N. L., Fryer J. P., Homburger H., Hunter J., Weinshenker B. G., Krecke K., Lucchinetti C. F., Pittock S. J., CNS aquaporin-4 autoimmunity in children. Neurology 2008 71 2 93 100 2-s2.0-67649397509 10.1212/01.wnl.0000314832.24682.c6
59. Peña J. A., Ravelo M. E., Mora-La Cruz E., Montiel-Nava C., NMO in pediatric patients: brain involvement and clinical expression. Arquivos de Neuro-Psiquiatria 2011 69 1 34 38 2-s2.0-79952347471
60. Morrow M. J., Wingerchuk D., Neuromyelitis optica. Journal of Neuro-Ophthalmology 2012 32 2 154 166 10.1097/WNO.0b013e31825662f1
61. Tillema J. M., McKeon A., The spectrum of neuromyelitis optica (NMO) in childhood. Journal of Child Neurology 2012 27 11 1437 1447 10.1177/ 0883073812451495
62. Banwell B., Tenembaum S., Lennon V. A., Ursell E., Kennedy J., Bar-Or A., Weinshenker B. G., Lucchinetti C. F., Pittock S. J., Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology 2008 70 5 344 352 2-s2.0-39749113222 10.1212/01.wnl.0000284600.80782.d5 (Pubitemid 351653396)
63. Verhey L. H., van Pelt-Gravesteijnc E. D., Ketelslegersc A., Neuteboomd R. F., Catsman-Berrevoetsd C. E., Feldmane B. M., Streineri D. L., Sledl J. G., Hintzenc B Banwella R. Q., Validation of MRI predictors of multiple sclerosis diagnosis in children with acute CNS demyelination. Multiple Sclerosis and Related Disorders 2013 2 3 193 199 10.1016/j.msard.2012.12.003
64. Gorman M. P., Healy B. C., Polgar-Turcsanyi M., Chitnis T., Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Archives of Neurology 2009 66 1 54 59 2-s2.0-58449087670 10.1001/archneurol. 2008.505
65. Julian L., Serafin D., Charvet L., Ackerson J., Benedict R., Braaten E., Brown T., O'Donnell E., Parrish J., Preston T., Zaccariello M., Belman A., Chitnis T., Gorman M., Ness J., Patterson M., Rodriguez M., Waubant E., Weinstock-Guttman B., Yeh A., Krupp L. B., Cognitive impairment occurs in children and adolescents with multiple sclerosis: results from a United States network. Journal of Child Neurology 2013 28 1 102 107 10.1177/0883073812464816
66. MacAllister W. S., Boyd J. R., Holland N. J., Milazzo M. C., Krupp L. B., The psychosocial consequences of pediatric multiple sclerosis. Neurology 2007 68 16, supplement 2 S66 S69 2-s2.0-34247222727 10.1212/01.wnl.0000259420.54635. 63 (Pubitemid 46626007)
67. MacAllister W. S., Christodoulou C., Milazzo M., Krupp L. B., Longitudinal neuropsychological assessment in pediatric multiple sclerosis. Developmental Neuropsychology 2007 32 2 625 644 2-s2.0-34848896021 (Pubitemid 47493427)
68. Glanz B. I., Healy B. C., Hviid L. E., Chitnis T., Weiner H. L., Cognitive deterioration in patients with early multiple sclerosis: a 5-year study. Journal of Neurology, Neurosurgery and Psychiatry 2012 83 1 38 43 2-s2.0-84155165482 10.1136/jnnp.2010.237834
69. O'Mahony J., Bar-Or A., Arnold D. L., Sadovnick A. D., Marrie R. A., Banwell B., Masquerades of acquired demyelination in children: experiences of a national demyelinating disease program. Journal of Child Neurology 2013 28 2 184 197 10.1177/0883073812443006
70. Hahn J. S., Pohl D., Rensel M., Rao S., Differential diagnosis and evaluation in pediatric multiple sclerosis. Neurology 2007 68 16, supplement 2 S13 S22 2-s2.0-34247227654 10.1212/01.wnl.0000259403.31527.ef (Pubitemid 46626002)
71. Twilt M., Benseler S. M., CNS vasculitis in children. Multiple Sclerosis and Related Disorders 2013 2 3 162 171 10.1016/j.msard.2012.11.002
72. McAdam L. C., Blaser S. I., Banwell B. L., Pediatric tumefactive demyelination: case series and review of the literature. Pediatric Neurology 2002 26 1 18 25 2-s2.0-0036157690 10.1016/S0887-8994(01)00322-8 (Pubitemid 34112477)
73. Riva D., Chiapparini L., Pollo B., Balestrini M. R., Massimino M., Milani N., A case of pediatric tumefactive demyelinating lesion misdiagnosed and treated as glioblastoma. Journal of Child Neurology 2008 23 8 944 947 2-s2.0-48449084768 10.1177/0883073808315419
74. Waubant E., Chabas D., Okuda D. T., Glenn O., Mowry E., Henry R. G., Strober J. B., Soares B., Wintermark M., Pelletier D., Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults. Archives of Neurology 2009 66 8 967 971 2-s2.0-68549092842 10.1001/archneurol.2009.135
75. Sadaka Y., Verhey L. H., Shroff M. M., Branson H. M., Arnold D. L., Narayanan S., Sled J. G., Bar-Or A., Sadovnick A. D., McGowan M., Marrie R. A., Banwell B., 2010 McDonald criteria for diagnosing pediatric multiple sclerosis. Annals of Neurology 2012 72 2 211 223 10.1002/ana.23575
76. Chabas D., Castillo-Trivino T., Mowry E. M., Strober J. B., Glenn O. A., Waubant E., Vanishing MS T2-bright lesions before puberty: a distinct MRI phenotype? Neurology 2008 71 14 1090 1093 2-s2.0-54549122739 10.1212/01.wnl.0000326896.66714.ae
77. Chabas D., Ness J., Belman A., Yeh E. A., Kuntz N., Gorman M. P., Strober J. B., de Kouchkovsky I., McCulloch C., Chitnis T., Rodriguez M., Weinstock-Guttman B., Krupp L. B., Waubant E., Younger children with MS have a distinct CSF inflammatory profile at disease onset. Neurology 2010 74 5 399 405 2-s2.0-76349099319 10.1212/WNL.0b013e3181ce5db0
78. Dale R. C., de Sousa C., Chong W. K., Cox T. C. S., Harding B., Neville B. G. R., Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain 2000 123 12 2407 2422 2-s2.0-0033635692
79. Ghezzi A., Pozzilli C., Liguori M., Marrosu M. G., Milani N., Milanese C., Simone I., Zaffaroni M., Prospective study of multiple sclerosis with early onset. Multiple Sclerosis 2002 8 2 115 118 2-s2.0-0036198858 10.1191/1352458502ms786oa (Pubitemid 34256747)
80. Pohl D., Rostasy K., Reiber H., Hanefeld F., CSF characteristics in early-onset multiple sclerosis. Neurology 2004 63 10 1966 1967 2-s2.0-8844267537 (Pubitemid 39532406)
81. Pohl D., Rostasy K., Treiber-Held S., Brockmann K., Gärtner J., Hanefeld F., Pediatric multiple sclerosis: detection of clinically silent lesions by multimodal evoked potentials. Journal of Pediatrics 2006 149 1 125 127 2-s2.0-33745961746 10.1016/j.jpeds.2006.01.003 (Pubitemid 44062528)
82. Costello F., Coupland S., Hodge W., Lorello G. R., Koroluk J., Pan Y. I., Freedman M. S., Zackon D. H., Kardon R. H., Quantifying axonal loss after optic neuritis with optical coherence tomography. Annals of Neurology 2006 59 6 963 969 2-s2.0-33744826785 10.1002/ana.20851 (Pubitemid 43830928)
83. Frohman E., Costello F., Zivadinov R., Stuve O., Conger A., Winslow H., Trip A., Frohman T., Balcer L., Optical coherence tomography in multiple sclerosis. Lancet Neurology 2006 5 10 853 863 2-s2.0-33750592482 10.1016/S1474-4422(06)70573-7 (Pubitemid 44715820)
84. Gordon-Lipkin E., Chodkowski B., Reich D. S., Smith S. A., Pulicken M., Balcer L. J., Frohman E. M., Cutter G., Calabresi P. A., Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology 2007 69 16 1603 1609 2-s2.0-35848949771 10.1212/01.wnl.0000295995.46586.ae (Pubitemid 350287144)
85. Henderson A. P. D., Trip S. A., Schlottmann P. G., Altmann D. R., Garway-Heath D. F., Plant G. T., Miller D. H., An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography. Brain 2008 131 part 1 277 287 2-s2.0-37549016294 10.1093/brain/awm285
86. Yeh E. A., Weinstock-Guttman B., Lincoff N., Reynolds J., Weinstock A., Madurai N., Agarwal N., Buch P., Karpinski M., Ramanathan M., Retinal nerve fiber thickness in inflammatory demyelinating diseases of childhood onset. Multiple Sclerosis 2009 15 7 802 810 2-s2.0-67649344399 10.1177/1352458509104586
87. Yeh E. A., Management of children with multiple sclerosis. Pediatric Drugs 2012 14 3 165 177 2-s2.0-84859804793 10.2165/11599880-000000000-00000
88. Ghezzi A., Amato M. P., Capobianco M., Gallo P., Marrosu G., Martinelli V., Milani N., Milanese C., Moiola L., Patti F., Pilato V., Pozzilli C., Trojano M., Zaffaroni M., Comi G., Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an Italian co-operative study. Multiple Sclerosis 2005 11 4 420 424 2-s2.0-22144446357 10.1191/1352458505ms1206oa (Pubitemid 40984236)
89. Yeh E. A., Current therapeutic options in pediatric multiple sclerosis. Current Treatment Options in Neurology 2011 13 6 544 559 2-s2.0-81155159670 10.1007/s11940-011-0141-x
90. Chitnis T., Tenembaum S., Banwell B., Krupp L., Pohl D., Rostasy K., Yeh E. A., Bykova O., Wassmer E., Tardieu M., Kornberg A., Ghezzi A., Consensus statement: evaluation of new and existing therapeutics for pediatric multiple sclerosis. Multiple Sclerosis 2012 18 1 116 127 2-s2.0-84855965204 10.1177/1352458511430704
91. Chitnis T., Tardieu M., Amato M. P., Banwell B., Bar-Or A., Ghezzi A., Kornberg A., Krupp L. B., Pohl D., Rostasy K., Tenembaum S., Waubant E., Wassmer E., International Pediatric MS Study Group Clinical Trials Summit: meeting report. Neurology 2013 80 12 1161 1168 10.1212/WNL.0b013e318288694e